Article
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease.
Journal of thrombosis and haemostasis : JTH - 1 May 2006
Undas A, Celinska-Löwenhoff M, Löwenhoff T, Szczeklik A
Abstract excerpt
BACKGROUND: Aspirin increases fibrin clot porosity and susceptibility to lysis. It is unknown whether other drugs, in combination with aspirin, used in the treatment of coronary artery disease (CAD) might affect clot structure and resistance to lysis. AIM: The aim of the study was to assess the effects of statins, fibrates, or angiotensin-converting enzyme inhibitors (ACEIs) on fibrin clot properties. PATIENTS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
